medicine stop limited
medicine stop limited Company Information
Company Number
08989865
Website
-Registered Address
27 quayside, newcastle upon tyne, tyne and wear, NE1 3DE
Industry
Dispensing chemist in specialised stores
Telephone
-
Next Accounts Due
January 2026
Group Structure
View All
Shareholders
greenbow properties ltd 75%
parveen malik 25%
medicine stop limited Estimated Valuation
Pomanda estimates the enterprise value of MEDICINE STOP LIMITED at £0 based on a Turnover of £0 and 0.27x industry multiple (adjusted for size and gross margin).
medicine stop limited Estimated Valuation
Pomanda estimates the enterprise value of MEDICINE STOP LIMITED at £0 based on an EBITDA of £-50 and a 4.08x industry multiple (adjusted for size and gross margin).
medicine stop limited Estimated Valuation
Pomanda estimates the enterprise value of MEDICINE STOP LIMITED at £639 based on Net Assets of £1k and 0.64x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Medicine Stop Limited Overview
Medicine Stop Limited is a live company located in tyne and wear, NE1 3DE with a Companies House number of 08989865. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in April 2014, it's largest shareholder is greenbow properties ltd with a 75% stake. Medicine Stop Limited is a established, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Medicine Stop Limited Health Check
There is insufficient data available to calculate a health check for Medicine Stop Limited. Company Health Check FAQs
0 Strong
0 Regular
0 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Medicine Stop Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Medicine Stop Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- Medicine Stop Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Medicine Stop Limited
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Medicine Stop Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Medicine Stop Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Medicine Stop Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Medicine Stop Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Medicine Stop Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Medicine Stop Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Medicine Stop Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Medicine Stop Limited
- - Industry AVG
MEDICINE STOP LIMITED financials
Medicine Stop Limited's latest turnover from April 2024 is estimated at 0 and the company has net assets of £1 thousand. According to their latest financial statements, we estimate that Medicine Stop Limited has no employees and maintains cash reserves of £1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||
| Other Income Or Grants | ||||||||||
| Cost Of Sales | ||||||||||
| Gross Profit | ||||||||||
| Admin Expenses | ||||||||||
| Operating Profit | ||||||||||
| Interest Payable | ||||||||||
| Interest Receivable | ||||||||||
| Pre-Tax Profit | ||||||||||
| Tax | ||||||||||
| Profit After Tax | ||||||||||
| Dividends Paid | ||||||||||
| Retained Profit | ||||||||||
| Employee Costs | ||||||||||
| Number Of Employees | ||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 0 | 0 | 0 | 0 |
| total assets | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 0 | 0 | 0 | 0 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| net assets | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 0 | 0 | 0 | 0 |
| total shareholders funds | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 0 | 0 | 0 | 0 |
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Operating Profit | ||||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Tax | ||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||
| Investing Activities | ||||||||||
| capital expenditure | ||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||
| Financing Activities | ||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||
| interest | ||||||||||
| cash flow from financing | ||||||||||
| cash and cash equivalents | ||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 1,000 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 1,000 | 0 | 0 | 0 | 0 |
medicine stop limited Credit Report and Business Information
Medicine Stop Limited Competitor Analysis
Perform a competitor analysis for medicine stop limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other established companies, companies in NE1 area or any other competitors across 12 key performance metrics.
medicine stop limited Ownership
MEDICINE STOP LIMITED group structure
Medicine Stop Limited has no subsidiary companies.
medicine stop limited directors
Medicine Stop Limited currently has 2 directors. The longest serving directors include Mrs Shaheena Malik (Apr 2014) and Mr Amjed Malik (Apr 2014).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Shaheena Malik | United Kingdom | 65 years | Apr 2014 | - | Director |
| Mr Amjed Malik | 67 years | Apr 2014 | - | Director |
P&L
April 2024turnover
0
0%
operating profit
-50
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
April 2024net assets
1k
0%
total assets
1k
0%
cash
1k
0%
net assets
Total assets minus all liabilities
Similar Companies
medicine stop limited company details
company number
08989865
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
April 2014
age
10
incorporated
UK
accounts
Dormant
ultimate parent company
previous names
N/A
last accounts submitted
April 2024
address
27 quayside, newcastle upon tyne, tyne and wear, NE1 3DE
accountant
-
auditor
-
medicine stop limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to medicine stop limited.
medicine stop limited Companies House Filings - See Documents
| date | description | view/download |
|---|
